Talphera, Inc. (NASDAQ:TLPH) Q1 2025 Earnings Conference Call May 14, 2025 4:30 PM ET
Company Participants
Raffi Asadorian – Chief Financial Officer
Vincent Angotti – Chief Executive Officer
Shakil Aslam – Chief Medical Officer
Conference Call Participants
Operator
Welcome to the Talphera First Quarter 2025 Financial Results Conference Call. This call is being webcast live via the Events page of the Investors section of Talphera’s website at www.talphera.com. You may listen to a replay of this webcast by going to the Investors section of Talphera’s website.
I would now like to turn the call over to Raffi Asadorian, Talphera’s Chief Financial Officer.
Raffi Asadorian
Thank you for joining us on the call today. Today, we announced our first quarter 2025 financial results and associated business updates in a press release. With me today are Vincent Angotti, our Chief Executive Officer; and Dr. Shakil Aslam, Talphera’s Chief Medical Officer.
Before we begin, I want to remind listeners that during this call, we will likely make forward-looking statements within the meaning of the federal securities laws. These forward-looking statements involve risks and uncertainties regarding the operations and future results of Talphera. Please refer to our press release in addition to the company’s periodic current and annual reports filed with the SEC for a discussion of the risks associated with such forward-looking statements. These documents can also be found on our website within the Investors section.
I’ll now hand the call to Vince.
Vincent Angotti
Thanks, Raffi. Good afternoon, and thank you to everyone joining our call today. It’s only been about 6 weeks since our last call, so we’re going to keep our prepared remarks brief.
We began 2025 with strong momentum with a focus on the execution of our NEPHRO CRRT trial that resulted in the approval from the FDA on
#Talphera #TLPH #Earnings #Call #Transcript